{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:51:48Z","timestamp":1791157908862,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-04953-x","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T06:24:52Z","timestamp":1783491892000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Engineering of siRNA molecules to silence SphK1 mRNA for therapeutic intervention in triple-negative breast cancer: An In Silico and In Vitro Analysis"],"prefix":"10.1007","volume":"17","author":[{"given":"Siddesh V.","family":"Siddalingegowda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhargav","family":"Shreevatsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhigna","family":"Nagaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anisha","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Dharmashekara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwini","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiva Prasad","family":"Kollur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Shivamallu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"issue":"3","key":"4953_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.5306\/wjco.v13.i3.209","volume":"13","author":"R Mehrotra","year":"2022","unstructured":"Mehrotra R, Yadav K. Breast cancer in India: present scenario and the challenges ahead. World J Clin Oncol. 2022;13(3):209\u201318. https:\/\/doi.org\/10.5306\/wjco.v13.i3.209.","journal-title":"World J Clin Oncol"},{"issue":"2","key":"4953_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s10549-024-07264-3","volume":"205","author":"V Kulothungan","year":"2024","unstructured":"Kulothungan V, Ramamoorthy T, Sathishkumar K, Mohan R, Tomy N, Miller GJ, Mathur P. Burden of female breast cancer in India: estimates of YLDs, YLLs, and DALYs at national and subnational levels based on the national cancer registry programme. Breast Cancer Res Treat. 2024;205(2):323\u201332. https:\/\/doi.org\/10.1007\/s10549-024-07264-3.","journal-title":"Breast Cancer Res Treat"},{"issue":"22","key":"4953_CR3","doi-asserted-by":"publisher","first-page":"36898","DOI":"10.18632\/oncotarget.16370","volume":"8","author":"D Hatoum","year":"2017","unstructured":"Hatoum D, Haddadi N, Lin Y, Nassif NT, McGowan EM. Mammalian sphingosine kinase (SphK) isoenzymes and isoform expression: challenges for SphK as an oncotarget. Oncotarget. 2017;8(22):36898\u2013929. https:\/\/doi.org\/10.18632\/oncotarget.16370.","journal-title":"Oncotarget"},{"issue":"1","key":"4953_CR4","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tips.2010.11.002","volume":"32","author":"H Chi","year":"2011","unstructured":"Chi H. Sphingosine-1-phosphate and immune regulation: trafficking and beyond. Trends Pharmacol Sci. 2011;32(1):16\u201324.","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"4953_CR5","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.yexcr.2015.02.025","volume":"333","author":"J Newton","year":"2015","unstructured":"Newton J, Lima S, Maceyka M, Spiegel S. Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy. Exp Cell Res. 2015;333(2):195\u2013200. https:\/\/doi.org\/10.1016\/j.yexcr.2015.02.025.","journal-title":"Exp Cell Res"},{"key":"4953_CR6","doi-asserted-by":"publisher","unstructured":"Wang X, Sun Y, Peng X, Naqvi SMAS, Yang Y, Zhang J, Chen M, Chen Y, Chen H, Yan H, Wei G, Hong P, Lu Y. The Tumorigenic Effect of Sphingosine Kinase 1 and Its Potential Therapeutic Target. Cancer Control. 2020 Jan-Dec;27(1):1073274820976664. https:\/\/doi.org\/10.1177\/1073274820976664.","DOI":"10.1177\/1073274820976664"},{"issue":"15","key":"4953_CR7","doi-asserted-by":"publisher","first-page":"5920","DOI":"10.18632\/oncotarget.1874","volume":"5","author":"A Datta","year":"2014","unstructured":"Datta A, Loo SY, Huang B, Wong L, Tan SS, Tan TZ, Lee SC, Thiery JP, Lim YC, Yong WP, Lam Y, Kumar AP, Yap CT. SPHK1 regulates proliferation and survival responses in triple-negative breast cancer. Oncotarget. 2014;5(15):5920\u201333. https:\/\/doi.org\/10.18632\/oncotarget.1874.","journal-title":"Oncotarget"},{"issue":"4","key":"4953_CR8","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/cells9040886","volume":"9","author":"LW Hii","year":"2020","unstructured":"Hii LW, Chung FF, Mai CW, Yee ZY, Chan HH, Raja VJ, Dephoure NE, Pyne NJ, Pyne S, Leong CO. Sphingosine kinase 1 regulates the survival of breast cancer stem cells and non-stem breast cancer cells by suppression of STAT1. Cells. 2020;9(4):886. https:\/\/doi.org\/10.3390\/cells9040886.","journal-title":"Cells"},{"issue":"20","key":"4953_CR9","doi-asserted-by":"publisher","first-page":"29563","DOI":"10.18632\/oncotarget.9007","volume":"7","author":"YC Wang","year":"2016","unstructured":"Wang YC, Tsai CF, Chuang HL, Chang YC, Chen HS, Lee JN, Tsai EM. Benzyl butyl phthalate promotes breast cancer stem cell expansion via SPHK1\/S1P\/S1PR3 signaling. Oncotarget. 2016;7(20):29563\u201376. https:\/\/doi.org\/10.18632\/oncotarget.9007.","journal-title":"Oncotarget"},{"issue":"4","key":"4953_CR10","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/MMBR.67.4.657-685.2003","volume":"67","author":"N Agrawal","year":"2003","unstructured":"Agrawal N, Dasaradhi PV, Mohmmed A, Malhotra P, Bhatnagar RK, Mukherjee SK. RNA interference: biology, mechanism, and applications. Microbiol Mol Biol Rev. 2003;67(4):657\u201385. https:\/\/doi.org\/10.1128\/MMBR.67.4.657-685.2003.","journal-title":"Microbiol Mol Biol Rev"},{"key":"4953_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12929-023-00981-9","volume":"30","author":"H Kang","year":"2023","unstructured":"Kang H, Ga YJ, Kim SH, et al. Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges. J Biomed Sci. 2023;30:88. https:\/\/doi.org\/10.1186\/s12929-023-00981-9.","journal-title":"J Biomed Sci"},{"key":"4953_CR12","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/418244a","volume":"418","author":"GJ Hannon","year":"2002","unstructured":"Hannon GJ. RNA interference. Nature. 2002;418:244\u201351. https:\/\/doi.org\/10.1038\/418244a.","journal-title":"Nature"},{"key":"4953_CR13","doi-asserted-by":"crossref","unstructured":"Yuki N. Ui-Tei Kumiko siRNA design software for a target gene-specific RNA interference, Front Genetics 2012;3. 10.3389\/fgene.2012.00102. 1664\u20138021.","DOI":"10.3389\/fgene.2012.00102"},{"key":"4953_CR14","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/nmeth780","volume":"2","author":"G Schramm","year":"2005","unstructured":"Schramm G, Ramey R. siRNA design including secondary structure target site prediction. Nat Methods. 2005;2:632. https:\/\/doi.org\/10.1038\/nmeth780.","journal-title":"Nat Methods"},{"issue":"4","key":"4953_CR15","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1002\/bit.21798","volume":"100","author":"JA Gredell","year":"2008","unstructured":"Gredell JA, Berger AK, Walton SP. Impact of target mRNA structure on siRNA silencing efficiency: a large-scale study. Biotechnol Bioeng. 2008;100(4):744\u201355. https:\/\/doi.org\/10.1002\/bit.21798.","journal-title":"Biotechnol Bioeng"},{"key":"4953_CR16","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.3390\/nano14211727","volume":"14","author":"J Driscoll","year":"2024","unstructured":"Driscoll J, Gondaliya P, Ziemer A, Yan IK, Gupta Y, Patel T. In Silico Design of Novel EpCAM-Binding Aptamers for Targeted Delivery of RNA Therapeutics. Nanomaterials. 2024;14:1727. https:\/\/doi.org\/10.3390\/nano14211727.","journal-title":"Nanomaterials"},{"key":"4953_CR17","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s43088-024-00472-2","volume":"13","author":"R Islam","year":"2024","unstructured":"Islam R, Shahriar A, Uddin MR, et al. Immunoinformatic and molecular docking approaches: siRNA prediction to silence cell surface binding protein of monkeypox virus. Beni-Suef Univ J Basic Appl Sci. 2024;13:17. https:\/\/doi.org\/10.1186\/s43088-024-00472-2.","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"issue":"11","key":"4953_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s13205-023-03767-w","volume":"13","author":"PS Ramalingam","year":"2023","unstructured":"Ramalingam PS, Arumugam S. Computational design and validation of effective siRNAs to silence oncogenic KRAS. 3 Biotech. 2023;13(11):350. https:\/\/doi.org\/10.1007\/s13205-023-03767-w.","journal-title":"3 Biotech"},{"key":"4953_CR19","doi-asserted-by":"publisher","first-page":"31708","DOI":"10.1038\/s41598-025-16936-z","volume":"15","author":"S Sriram","year":"2025","unstructured":"Sriram S, Palanichamy C, Subash PT, et al. Molecular dynamics simulations based siRNA design against GPR10 reveals stable RNAi therapeutics for hormone-dependent uterine fibroids. Sci Rep. 2025;15:31708. https:\/\/doi.org\/10.1038\/s41598-025-16936-z.","journal-title":"Sci Rep"},{"key":"4953_CR20","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/35078107","volume":"411","author":"SM Elbashir","year":"2001","unstructured":"Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 2001;411:494\u20138. https:\/\/doi.org\/10.1038\/35078107.","journal-title":"Nature"},{"key":"4953_CR21","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/bcr2644","volume":"12","author":"B Qin","year":"2010","unstructured":"Qin B, Cheng K. Silencing of the IKK\u03b5 gene by siRNA inhibits invasiveness and growth of breast cancer cells. Breast Cancer Res. 2010;12:R74. https:\/\/doi.org\/10.1186\/bcr2644.","journal-title":"Breast Cancer Res"},{"key":"4953_CR22","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.2147\/OTT.S180962","volume":"11","author":"L Su","year":"2018","unstructured":"Su L, Tian J, Sun J, Han N, Feng L, Yu B, Wang Y. Lentivirus-mediated siRNA knockdown of SPHK1 inhibits proliferation and tumorigenesis of neuroblastoma. Onco Targets Ther. 2018;11:7187\u201396. https:\/\/doi.org\/10.2147\/OTT.S180962.","journal-title":"Onco Targets Ther"},{"issue":"4","key":"4953_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s11596-007-0413-6","volume":"27","author":"L Wu","year":"2007","unstructured":"Wu L, Wang Y, Tian D. Knockdown of survivin expression by siRNA induces apoptosis of hepatocellular carcinoma cells. J Huazhong Univ Sci Technolog Med Sci. 2007;27(4):403\u20136. https:\/\/doi.org\/10.1007\/s11596-007-0413-6.","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"issue":"4","key":"4953_CR24","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/cells9040886","volume":"9","author":"L-W Hii","year":"2020","unstructured":"Hii L-W, Chung FF-L, Mai CW, Yee ZY, Chan HH, Raja VJ, Dephoure NE, Pyne NJ, Pyne S, Leong C-O. Sphingosine kinase 1 regulates the survival of breast cancer stem cells and non-stem breast cancer cells by suppression of STAT1. Cells. 2020;9(4):886. https:\/\/doi.org\/10.3390\/cells9040886.","journal-title":"Cells"},{"key":"4953_CR25","doi-asserted-by":"publisher","first-page":"1645905","DOI":"10.3389\/fonc.2025.1645905","volume":"15","author":"A Jain","year":"2025","unstructured":"Jain A, Motatis AKB, Dharmashekar C, Shreevatsa B, VS S, Srinivas M, Srinivasa SM, Prasad PA, Rosell MNN, Codony-Servat R, Rangappa J, Iqbal S, Abass M, Amachawadi KS, Stupin RG, Kollur V, Shivamallu SP C and, Silina E. Repurposing risperidone as an anti-angiogenic agent for triple-negative breast cancer: a computational to in ovo investigation. Front Oncol. 2025;15:1645905. https:\/\/doi.org\/10.3389\/fonc.2025.1645905.","journal-title":"Front Oncol"},{"key":"4953_CR26","doi-asserted-by":"publisher","first-page":"29726","DOI":"10.1038\/s41598-025-12805-x","volume":"15","author":"M Hejazi","year":"2025","unstructured":"Hejazi M, Mahdavi B, Abedimanesh SZ. LINC00162 silencing enhances sorafenib sensitivity and inhibits thyroid cancer cells progression through modulation of MAPK signaling and apoptosis. Sci Rep. 2025;15:29726. https:\/\/doi.org\/10.1038\/s41598-025-12805-x.","journal-title":"Sci Rep"},{"key":"4953_CR27","doi-asserted-by":"publisher","first-page":"5313","DOI":"10.1016\/j.febslet.2005.08.055","volume":"579","author":"M Sukumar Sarkar","year":"2005","unstructured":"Sukumar Sarkar M, Maceyka NC, Hait SW, Paugh H, Sankala S, Milstien S, Spiegel. Sphingosine kinase 1 is required for migration, proliferation and survival of MCF-7 human breast cancer cells. FEBS Lett. 2005;579:5313\u20137. https:\/\/doi.org\/10.1016\/j.febslet.2005.08.055. ISSN 0014-5793.","journal-title":"FEBS Lett"},{"issue":"16","key":"4953_CR28","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1158\/0008-5472.CAN-18-3803","volume":"79","author":"S Acharya","year":"2019","unstructured":"Acharya S, Yao J, Li P, Zhang C, Lowery FJ, Zhang Q, Guo H, Qu J, Yang F, Wistuba II, Piwnica-Worms H, Sahin AA, Yu D. Sphingosine kinase 1 signaling promotes metastasis of triple-negative breast cancer. Cancer Res. 2019;79(16):4211\u201326. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-3803.","journal-title":"Cancer Res"},{"key":"4953_CR29","unstructured":"Charbe NB, Amnerkar ND, Ramesh B, Tambuwala MM, Bakshi HA, Alaa AA, Aljabali SC. Khadse, Rajendran Satheeshkumar, Saurabh Satija, Meenu Metha, Dinesh Kumar Chellappan, Garima Shrivastava, Gaurav Gupta, Poonam Negi, Kamal Dua, Flavia C. Zacconi."},{"key":"4953_CR30","doi-asserted-by":"publisher","unstructured":"Small. interfering RNA for cancer treatment: overcoming hurdles in delivery, Acta Pharmaceutica Sinica B, Volume 10, Issue 11, 2020, Pages 2075\u20132109, ISSN 2211\u20133835. https:\/\/doi.org\/10.1016\/j.apsb.2020.10.005","DOI":"10.1016\/j.apsb.2020.10.005"},{"issue":"9","key":"4953_CR31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.5732\/cjc.012.10280","volume":"32","author":"W Guo","year":"2013","unstructured":"Guo W, Chen W, Yu W, Huang W, Deng W. Small interfering RNA-based molecular therapy of cancers. Chin J Cancer. 2013;32(9):488\u201393. https:\/\/doi.org\/10.5732\/cjc.012.10280.","journal-title":"Chin J Cancer"},{"issue":"5","key":"4953_CR32","doi-asserted-by":"publisher","first-page":"101555","DOI":"10.1016\/j.xcrm.2024.101555","volume":"5","author":"PE Saw","year":"2024","unstructured":"Saw PE, Song E. Advancements in clinical RNA therapeutics: present developments and prospective outlooks. Cell Rep Med. 2024;5(5):101555. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101555.","journal-title":"Cell Rep Med"},{"key":"4953_CR33","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12935-019-1014-8","volume":"19","author":"P Wang","year":"2019","unstructured":"Wang P, Yuan Y, Lin W, et al. Roles of sphingosine-1-phosphate signaling in cancer. Cancer Cell Int. 2019;19:295. https:\/\/doi.org\/10.1186\/s12935-019-1014-8.","journal-title":"Cancer Cell Int"},{"key":"4953_CR34","doi-asserted-by":"publisher","first-page":"941643","DOI":"10.3389\/fonc.2022.941643","volume":"12","author":"RZ Li","year":"2022","unstructured":"Li RZ, Wang XR, Wang J, Xie C, Wang XX, Pan HD, Meng WY, Liang TL, Li JX, Yan PY, Wu QB, Liu L, Yao XJ, Leung EL. The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance. Front Oncol. 2022;12:941643. https:\/\/doi.org\/10.3389\/fonc.2022.941643.","journal-title":"Front Oncol"},{"key":"4953_CR35","doi-asserted-by":"publisher","unstructured":"Chinh Chung D, Thanh Long L, Nghia Son H, Tri Bao L, Minh Si D. Dong le V. Downregulation of Vascular Endothelial Growth Factor Enhances Chemosensitivity by Induction of Apoptosis in Hepatocellular Carcinoma Cells. Cell J. 2015 Summer;17(2):273\u201387. https:\/\/doi.org\/10.22074\/cellj.2016.3730.","DOI":"10.22074\/cellj.2016.3730"},{"key":"4953_CR36","doi-asserted-by":"publisher","unstructured":"Ngamcherdtrakul W, Yantasee W. siRNA therapeutics for breast cancer: recent efforts in targeting metastasis, drug resistance, and immune evasion. Transl Res. 2019;214:105\u2013120. https:\/\/doi.org\/10.1016\/j.trsl.2019.08.005. Epub 2019 Aug 19. Erratum in: Transl Res. 2020;217:77. doi: 10.1016\/j.trsl.2020.01.004.","DOI":"10.1016\/j.trsl.2019.08.005"},{"issue":"10","key":"4953_CR37","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3390\/ph13100294","volume":"13","author":"MI Sajid","year":"2020","unstructured":"Sajid MI, Moazzam M, Kato S, Yeseom Cho K, Tiwari RK. Overcoming barriers for siRNA therapeutics: from bench to bedside. Pharmaceuticals (Basel). 2020;13(10):294. https:\/\/doi.org\/10.3390\/ph13100294.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"23","key":"4953_CR38","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.3390\/cancers15235647","volume":"15","author":"S Molenda","year":"2023","unstructured":"Molenda S, Sikorska A, Florczak A, Lorenc P, Dams-Kozlowska H. Oligonucleotide-based therapeutics for STAT3 targeting in cancer-drug carriers matter. Cancers (Basel). 2023;15(23):5647. https:\/\/doi.org\/10.3390\/cancers15235647.","journal-title":"Cancers (Basel)"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-04953-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04953-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-04953-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T23:09:26Z","timestamp":1791155366000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-04953-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4953"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-04953-x","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"assertion":[{"value":"10 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors agreed to publication in the journal.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1404"}}